| The role of HER2 in cancer therapy and targeted drug delivery W Tai, R Mahato, K Cheng Journal of controlled release 146 (3), 264-275, 2010 | 640 | 2010 |
| ATP-triggered anticancer drug delivery R Mo, T Jiang, R DiSanto, W Tai, Z Gu Nature communications 5 (1), 3364, 2014 | 623 | 2014 |
| Emerging micro-and nanotechnology based synthetic approaches for insulin delivery R Mo, T Jiang, J Di, W Tai, Z Gu Chemical society reviews 43 (10), 3595-3629, 2014 | 430 | 2014 |
| Prodrugs for improving tumor targetability and efficiency R Mahato, W Tai, K Cheng Advanced drug delivery reviews 63 (8), 659-670, 2011 | 380 | 2011 |
| Functional peptides for siRNA delivery W Tai, X Gao Advanced drug delivery reviews 110, 157-168, 2017 | 182 | 2017 |
| Bio-inspired synthetic nanovesicles for glucose-responsive release of insulin W Tai, R Mo, J Di, V Subramanian, X Gu, JB Buse, Z Gu Biomacromolecules 15 (10), 3495-3502, 2014 | 166 | 2014 |
| Clickable protein nanocapsules for targeted delivery of recombinant p53 protein M Zhao, Y Liu, RS Hsieh, N Wang, W Tai, KI Joo, P Wang, Z Gu, Y Tang Journal of the American chemical society 136 (43), 15319-15325, 2014 | 114 | 2014 |
| Development of a peptide–drug conjugate for prostate cancer therapy W Tai, RS Shukla, B Qin, B Li, K Cheng Molecular pharmaceutics 8 (3), 901-912, 2011 | 104 | 2011 |
| Dramatic enhancement of the detection limits of bioassays via ultrafast deposition of polydopamine J Li, MA Baird, MA Davis, W Tai, LS Zweifel, KMA Waldorf, M Gale Jr, ... Nature biomedical engineering 1 (6), 0082, 2017 | 97 | 2017 |
| Expression profile and functional activity of peptide transporters in prostate cancer cells W Tai, Z Chen, K Cheng Molecular pharmaceutics 10 (2), 477-487, 2013 | 92 | 2013 |
| Folding graft copolymer with pendant drug segments for co-delivery of anticancer drugs W Tai, R Mo, Y Lu, T Jiang, Z Gu Biomaterials 35 (25), 7194-7203, 2014 | 78 | 2014 |
| A ribonucleoprotein octamer for targeted siRNA delivery W Tai, J Li, E Corey, X Gao Nature biomedical engineering 2 (5), 326-337, 2018 | 73 | 2018 |
| Current aspects of siRNA bioconjugate for in vitro and in vivo delivery W Tai Molecules 24 (12), 2211, 2019 | 72 | 2019 |
| Inhibition of breast cancer cell growth and invasiveness by dual silencing of HER-2 and VEGF W Tai, B Qin, K Cheng Molecular pharmaceutics 7 (2), 543-556, 2010 | 61 | 2010 |
| Cytosolic delivery of proteins by cholesterol tagging W Tai, P Zhao, X Gao Science advances 6 (25), eabb0310, 2020 | 42 | 2020 |
| Functional photoacoustic imaging of gastric acid secretion using pH-responsive polyaniline nanoprobes J Li, H Xiao, SJ Yoon, C Liu, D Matsuura, W Tai, L Song, M O’Donnell, ... Small (Weinheim an der Bergstrasse, Germany) 12 (34), 4690, 2016 | 38 | 2016 |
| Design, synthesis, and biological evaluation of caprolactam-modified bengamide analogues G Liu, YM Ma, WY Tai, CM Xie, YN Li, J Li, FJ Nan ChemMedChem 3 (1), 74-78, 2008 | 32 | 2008 |
| Chemical modulation of siRNA lipophilicity for efficient delivery W Tai Journal of controlled release 307, 98-107, 2019 | 30 | 2019 |
| Stably doped conducting polymer nanoshells by surface initiated polymerization J Li, SJ Yoon, BY Hsieh, W Tai, M O’Donnell, X Gao Nano letters 15 (12), 8217-8222, 2015 | 30 | 2015 |
| Facile synthesis of versatile functionalized amino caprolactams using RCM reactions of α-amino acrylamide G Liu, WY Tai, YL Li, FJ Nan Tetrahedron letters 47 (19), 3295-3298, 2006 | 30 | 2006 |
Zhen GuZhejiang University; UCLA; UNC Chapel Hill, NC State UniversityVerified email at ucla.edu
